Dr. Calvin Stiller appointed Chair of the Board of Directors of the Ontario Institute for Cancer Research

    TORONTO, Jan. 21 /CNW/ - The Board of Directors of the Ontario Institute
for Cancer Research (OICR) has appointed Dr. Calvin Stiller as Chair of the
Board. He succeeds Dr. John Evans, who was the first Chair and who will
continue to serve on the Board.
    "Dr. Stiller brings an unmatched breadth of knowledge, experience and
wisdom to OICR", said Dr. Evans. "He is uniquely positioned to provide
oversight and guidance to the Institute as it tackles the large issues in
cancer research."
    "Dr. Stiller's career encompasses a lifelong dedication to innovation,
science, business and public service. His appointment as chair of the Ontario
Institute for Cancer Research can only help bolster Ontario's position as a
global leader in health sciences and cancer research," said Minister of
Research and Innovation John Wilkinson.
    Dr. Stiller was instrumental in the founding of OICR and has been a
member of the Board of Directors since it was created in December 2005. A
lifelong innovator, Dr. Stiller's work encompasses science, business and
public service. He received his medical degree from the University of
Saskatchewan in 1965 and his fellowship in the Royal College of Physicians and
Surgeons of Canada in 1972. He was the principal investigator on the Canadian
multi-centre study that established the effectiveness of Cyclosporine in
transplantation, which led to its worldwide use as a first-line therapy for
transplant rejection.
    In addition to establishing the Multi-Organ Transplant Service in London
and serving as its chief for over a decade, Dr. Stiller co-founded the MaRS
Centre, the J. Allyn Taylor International Prize in Medicine and the Canadian
Medical Hall of Fame. He founded three companies that have provided seed
funding for 50 technologies and created over a quarter of a billion dollars in
economic activity.
    Dr. Stiller is the Chair of Genome Canada and participates on the boards
of directors of several companies. A member of the Order of Canada and the
Order of Ontario, Dr. Stiller has received numerous awards.

    About OICR

    OICR is a centre of excellence, moving Ontario to the forefront of
discovery and innovation. It is dedicated to research in prevention, early
detection, diagnosis, treatment and control of cancer. OICR is a
not-for-profit corporation funded by the Government of Ontario through the
Ministry of Research and Innovation.

For further information:

For further information: Rhea Cohen, Director of Communications, E-mail:
rhea.cohen@oicr.on.ca, Telephone: (416) 673-6642, Mobile: (416) 671-2846

Organization Profile

Ontario Institute for Cancer Research

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890